14th Oct 2014 17:34
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 14 October 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1404.00 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $45.63 per ADS following the notional re-investment of the dividend paid to shareholders on 2 October 2014.
Director/PDMR | Ordinary Shares | ADSs |
Sir Andrew Witty | 18,700.225 | |
Dr M M Slaoui | 5,761.611 | |
Mr S Dingemans | 7,854.435 | |
Mr R G Connor | 2,568.688 | |
Mrs D P Connelly | 2,395.995 | |
Mr J Ford | 309.896 | |
Mr S A Hussain | 6,371.575 | |
Mr W C Louv | 1,690.149 | |
Mr D S Redfern | 2,704.765 | |
Ms C Thomas | 3,732.993 | |
Mr P C Thomson | 1,820.901 | |
Mr D E Troy | 3,424.225 | |
Dr P J T Vallance | 7,777.092 | |
Ms E Walmsley | 4,520.938 | |
Mrs V A Whyte | 517.597 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
14 October 2014
Related Shares:
Glaxosmithkline